Business

Express Scripts closes another Fort Worth facility; 227 workers lose jobs

Express Scripts is shuttering its second facility in Fort Worth following its 2012 merger with Medco Health Solutions.
Express Scripts is shuttering its second facility in Fort Worth following its 2012 merger with Medco Health Solutions. AP

Less than a year after closing a prescription processing center in far east Fort Worth, Express Scripts, the nation’s largest manager of prescription drug benefits, has cut 227 jobs at a facility in the Fossil Creek business park.

David Whitrap, a spokesman for the St. Louis-based company, said employees at the facility, 5450 N. Riverside Dr., were told on April 22 and released the same day. They will be paid for 60 days, he said, and the facility will be vacated by the end of June.

“The decision to reduce our workforce is a difficult one,” Whitrap said.

The closing is part of a nationwide consolidation of the company’s front-end pharmacy operations, where prescriptions are submitted, following the 2012 merger with Medco Health Solutions, Whitrap said.

No medication was being dispensed from the Riverside Drive location.

In November, 400 Express Scripts employees nationwide, including 90 in the St. Louis area, were given layoff notices.

In May 2014, Express Scripts cut 566 jobs in North Texas, including 418 in Fort Worth, when it closed a prescription processing center at 15001 Trinity Blvd. in the Centreport business park and a facility in Irving. At that time, the Riverside Drive facility, which then had about 500 employees, was not affected.

Express Scripts acquired the Riverside Drive facility from WellPoint in 2009 as part of its acquisition of WellPoint’s pharmacy division, NextRx. The facility dates to 1995 when it was a part of RxAmerica. The Centreport facility was acquired in the Medco acquisition.

Express Scripts still has 250 employees in Texas working at smaller facilities across the state and from home, Whitrap said.

Express Scripts is scheduled to release its first-quarter earnings Tuesday.

Sandra Baker, 817-390-7727

Twitter: @SandraBakerFWST

  Comments